"Rock 'n' Roll Star" is a song by English rock band Oasis. It is the opening track from their record breaking debut album, Definitely Maybe (1994). Like the majority of the band's songs from this era, it was written by lead guitarist Noel Gallagher. Noel said that "Rock 'n' Roll Star" was one of only three songs in which he wanted to say something: "I've pretty much summed up everything I wanted to say in "Rock 'n' Roll Star", "Live Forever" and "Cigarettes & Alcohol", after that I'm repeating myself, but in a different way". It became a fan favourite and was often played to close the band's gigs. It was released as a radio single in America. The song's video, directed by Nigel Dick, consists of clips of the band performing the song from their Live by the Sea gig, interspersed with clips of them on Southend Pier, in and around the amusement park, 'Adventure Island' then named 'Peter Pan's Playground' and in the bowling alley which was located on Southend Pier before it burnt down in June 1995 by Ian Thain of Basildon Essex. The song was featured on the band's 2000 live album and DVD, Familiar to Millions, and another live version was recorded at a 2 July 2005 concert at the City of Manchester Stadium and released on the band's single "Let There Be Love" in late 2005. The song appears on a promotional live CD (Metro Club Show in Chicago, recorded on 15 October 1994) that came with a copy of Don't Believe the Truth (2005) exclusively sold at Best Buy. The song was used as the opening theme of the 2010 music documentary series I'm in a Rock 'n' Roll Band!. Liam Gallagher performed the song as part of the One Love Manchester charity concert on 4 June 2017 in aid of those affected by the 2017 Manchester Arena bombing.

Mitragyna speciosa (commonly known as kratom) is a tropical evergreen tree in the coffee family native to Southeast Asia. M. speciosa is indigenous to Thailand, Indonesia, Malaysia, Myanmar, and Papua New Guinea, where it has been used in traditional medicines since at least the nineteenth century. Kratom has opioid properties and some stimulant-like effects. As of 2018, kratom's usefulness and safety as a therapeutic agent is unclear, since research into its use has been of poor quality. In February 2018, the United States' Food and Drug Administration (FDA) stated that there is no evidence that kratom is safe or effective for treating any condition. Some people take it for managing chronic pain, for treating opioid withdrawal symptoms, or – more recently – for recreational purposes. The onset of effects typically begins within five to ten minutes and lasts for two to five hours. Common minor side effects include nausea, vomiting, and constipation. More severe side effects may include respiratory depression (decreased breathing), seizure, addiction, and psychosis. Other side effects may include high heart rate and blood pressure, trouble sleeping, and, rarely, liver toxicity. When use is stopped, withdrawal symptoms may occur. Deaths have occurred with kratom both by itself and mixed with other substances. Over 18 months in 2016 and 2017, 152 overdose deaths involving kratom were reported in the United States, with kratom as the primary overdose agent in 91 of the deaths. Nine kratom-related deaths occurred in Sweden in 2011 and 2012, all involving a mixture of kratom with other opioids. Serious toxicity is relatively rare and generally appears at high doses or when kratom is used with other substances. In the United States kratom use has increased rapidly between 2011 to 2017. As of 2018, there is growing international concern about a possible threat to public health from kratom use. In some jurisdictions, its sale and importation have been restricted, and several public health authorities have raised alerts. Kratom is a controlled substance in 16 countries and, in 2014, the FDA banned importing and manufacturing of kratom as a dietary supplement. In the United States, there is consideration to make it a Schedule I drug. Sometimes, the finished product is mixed with other psychoactive drugs, such as caffeine and codeine. In 2019, the FDA warned consumers that kratom remains unapproved for interstate commerce, may be unsafe in commercially available products, and is on an import alert which would lead to confiscation of imported supplies.